Published: 6 July 2023
Committees
Medicines Assesment Advisory Committee
Agenda for the 123rd meeting of the Medicines Assessment Advisory Committee to be held on 27 July 2023
1 |
Welcome |
2 |
Apologies |
3 |
Declaration of conflicts of interest |
4 |
Applications for consent to distribute a new medicine under section 20 of the Medicines Act 1981 (referred by the Minister of Health under section 22(2)) |
4.1 |
Maxigesic Junior, oral suspension (paracetamol/ ibuprofen), AFT Pharmaceuticals LtdMaxigesic Junior is an oral suspension containing paracetamol (160 mg/5mL) and ibuprofen (48 mg/5mL) and is indicated for the temporary relief of pain and/or inflammation in children under 12 years of age. This application is being referred to the Committee for independent advice as to whether the Minister of Health (or their delegate) should grant consent for sale, supply and distribution of the proposed product in Aotearoa. |
5. |
GENERAL BUSINESS |
6. |
DATE OF NEXT MEETING |